Get the Stockscreener App
31.53
1.93%
-0.62
After Hours:
31.53
Procept Biorobotics Corp stock is traded at $31.53, with a volume of 728.75K.
It is down -1.93% in the last 24 hours and down -0.47% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$32.15
Open:
$31.81
24h Volume:
728.75K
Relative Volume:
0.53
Market Cap:
$1.76B
Revenue:
$249.12M
Net Income/Loss:
$-90.19M
P/E Ratio:
-18.55
EPS:
-1.7
Net Cash Flow:
$-88.21M
1W Performance:
-3.64%
1M Performance:
-0.47%
6M Performance:
-44.60%
1Y Performance:
-61.05%
1-Day Range:
$31.23
$31.93
1-Week Range:
$31.23
$33.28
52-Week Range:
$27.80
$89.49
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
31.53 | 1.80B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
125.78 | 216.61B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.01 | 141.96B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.12 | 134.80B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.66 | 123.27B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.20 | 50.45B | 5.88B | 1.34B | 799.60M | 2.3489 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | UBS | Buy |
| Dec-08-25 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
How Investors Are Reacting To PROCEPT BioRobotics (PRCT) UBS Coverage Initiation And 2027 Profitability Outlook - simplywall.st
What Wall Street predicts for PROCEPT BioRobotics Corporation stock priceConsumer Goods Stocks & Free Record-Breaking Gains - Bollywood Helpline
Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) - Finviz
Promising growth forecasts leading to analysts’ optimism for Procept Biorobotics (PRCT) - MSN
Promising Growth Forecasts Leading to Analysts’ Optimism for Procept Biorobotics (PRCT) - Yahoo Finance
15 Most Promising Mid-Cap Healthcare Stocks Under $50 - Insider Monkey
Aug EndMonth: What Wall Street predicts for PROCEPT BioRobotics Corporation stock priceJuly 2025 Gainers & AI Driven Stock Movement Reports - Улправда
Transcript : PROCEPT BioRobotics Corporation Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-02-2025 08 - marketscreener.com
Will PROCEPT BioRobotics Corporation stock outperform value stocksMarket Risk Summary & Technical Pattern Alert System - DonanımHaber
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Procept BioRobotics price target lowered to $47 from $50 at Truist - TipRanks
Truist Financial Has Lowered Expectations for PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price - MarketBeat
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Cuts Target Price to $47 - 富途牛牛
Truist Securities Adjusts Price Target on PROCEPT BioRobotics to $47 From $50, Maintains Buy Rating - marketscreener.com
Procept BioRobotics initiated with a buy at UBS - MSN
3 Underrated Robotics Stocks Poised for Huge Gains - Investing.com
PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Shareholders Might Be Looking For Exit - 富途牛牛
Squarepoint Ops LLC Decreases Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Downgraded by Wall Street Zen to Sell - MarketBeat
PROCEPT BioRobotics Corporation $PRCT Shares Bought by Eventide Asset Management LLC - MarketBeat
Bellevue Group AG Acquires 74,355 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS Initiates Coverage of PROCEPT BioRobotics (PRCT) with Buy Recommendation - Nasdaq
UBS initiates Procept BioRobotics stock with Buy rating on utilization growth - Investing.com Australia
PRCT FinancialsIncome Statement - Quiver Quantitative
Procept BioRobotics initiated with a Buy at UBS - TipRanks
UBS Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Raises Target Price to $62 - 富途牛牛
Promising Growth and Investment Opportunity for PROCEPT BioRobotics: Analyst Buy Rating - TipRanks
Frontier Capital Management Co. LLC Acquires 203,602 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS initiates Procept BioRobotics stock with Buy rating on utilization growth By Investing.com - Investing.com South Africa
PROCEPT BioRobotics (PRCT): Reassessing Valuation After BofA Downgrade and Slower Aquablation Growth Concerns - simplywall.st
Axa S.A. Purchases 63,519 Shares of PROCEPT BioRobotics Corporation $PRCT - Defense World
Next Century Growth Investors LLC Buys 62,112 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Federated Hermes Inc. Acquires 25,863 Shares of PROCEPT BioRobotics Corporation $PRCT - Defense World
Does PROCEPT BioRobotics (PRCT) Slower Aquablation Uptake Recast Its Long-Term Market Penetration Story? - Yahoo Finance
Does Slower Aquablation Growth at PROCEPT (PRCT) Hint At A Transition In Its Long-Term Story? - Sahm
PROCEPT BioRobotics Faces Slower Growth As BofA Lowers Rating - Finimize
PROCEPT BioRobotics’ (PRCT) “Neutral” Rating Reaffirmed at Bank of America - Defense World
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap DownHere's Why - MarketBeat
PROCEPT BioRobotics has Large Market Opportunity, but Utilization Growth has Slowed, BofA Says - marketscreener.com
Procept Biorobotics Shares Slide Amid Downgrade - TipRanks
Procept BioRobotics downgraded to neutral at BofA on slowing utilization - MSN
PROCEPT BioRobotics (NASDAQ:PRCT) Given "Neutral" Rating at Bank of America - MarketBeat
Procept BioRobotics stock downgraded by BofA on slowing growth - Investing.com Australia
PROCEPT BioRobotics Corporation $PRCT Shares Acquired by Thematics Asset Management - MarketBeat
Wall Street Zen Upgrades PROCEPT BioRobotics (NASDAQ:PRCT) to Hold - MarketBeat
Wall Street analysts’ outlook for Procept BioRobotics Corp (PRCT) - setenews.com
Is PROCEPT BioRobotics Corporation stock a buy before product launchesWeekly Stock Report & Short-Term High Return Ideas - Newser
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 7.5%What's Next? - MarketBeat
Granite Investment Partners LLC Makes New Investment in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Mackenzie Financial Corp Buys New Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):